Epidemiologic, Laboratory, and Clinical Characterization of Individuals With Ocular Diseases
NCT ID: NCT00249392
Last Updated: 2008-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
800 participants
OBSERVATIONAL
2004-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metabolomics: A Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration
NCT04241536
A Population-based Study of Macular Choroidal Neovascularization in a Chinese Population
NCT01666821
The Aging Eye Cohort Study
NCT05851287
Biomarkers of Common Eye Diseases
NCT04101604
Explainable Ocular Fundus Diseases Report Generation System
NCT05622565
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects will be allowed to participate if they self-identify as Chinese.
* Individuals with ocular diseases (cataract, retinopathy, age-related macular degeneration, glaucoma, retinal detachment, ocular tumor, etc.) will be allowed to participate. To participate in the study as the control, subjects should be confirmed without ocular diseases.
18 Years
89 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nanjing Medical University
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bin Wang, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Department of Pharmacology, Institute of Clinical Pharmacology, Nanjing Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Pharmacology, Institute of Clinical Pharmacology, Nanjing Medical University
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ICP008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.